Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.34%
SPX
-0.40%
IXIC
-0.34%
FTSE
+0.23%
N225
-0.65%
AXJO
0.00%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Recently from Cashu

publisher logo
Cashu

Incyte Stock Surges Amid Positive Myelofibrosis Therapy Outlook and Wells Fargo Upgrade

3 days ago
publisher logo
Cashu

Incyte Corporation: Navigating Mixed Analyst Views in Biopharmaceutical Sector Challenges

12 days ago
publisher logo
Cashu

Incyte Corporation (INCY): Navigating Mixed Analyst Sentiments in Biopharmaceutical Landscape

14 days ago

About

What does INCY do?
Yte is a Wilmington, Delaware-based biopharmaceutical company with 2,524 employees, focusing on hematology/oncology and inflammation/autoimmunity therapeutic areas. Its product portfolio includes JAKAFI, MONJUVI, and PEMAZYRE, among others.
Sector
💻 Health Care
IPO
CEO
Employees
2,617
Headquarters
Delaware, USA
Website
http://www.incyte.com

Key Stats

Market Cap
16.69B
Dividend Yield
0.00%
P/E Ratio
19.16
EPS
0.23
Revenue
4.24B
Avg. Volume
1.80M
Stocks
Health Care
incy
yte
NASDAQ: INCY
+0.35 (+0.41%)
86.55
USD
At close at Aug 21, 20:37 UTC
Summary
News
Signals
Benchmarks
Financials